Rapamycin inhibits cell growth by induction of apoptosis on hepatocellular carcinoma cells in vitro
- 30 April 2007
- journal article
- Published by Elsevier BV in Transplant Immunology
- Vol. 17 (3), 162-168
- https://doi.org/10.1016/j.trim.2006.12.003
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Selection of patients with hepatocellular carcinoma for liver transplantationBritish Journal of Surgery, 2005
- Opportunities for Targeted Therapies in Hepatocellular CarcinomaJournal of Clinical Oncology, 2005
- How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?Journal of Hepatology, 2005
- Management of hepatocellular cancerCurrent Treatment Options in Oncology, 2005
- Early detection and curative treatment of early-stage hepatocellular carcinoma.Clinical Gastroenterology and Hepatology, 2005
- Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinomaCancer, 2005
- The Molecular Signature of Metastases of Human Hepatocellular CarcinomaOncology, 2005
- Hepatocellular Carcinoma: The Need for ProgressJournal of Clinical Oncology, 2005
- Effect of Rapamycin Alone and in Combination with Antiangiogenesis Therapy in an Orthotopic Model of Human Pancreatic CancerClinical Cancer Research, 2004
- The Outcome of Liver Transplantation in Patients With Hepatocellular Carcinoma in the United States Between 1988 and 2001: 5-Year Survival Has Improved Significantly With TimeJournal of Clinical Oncology, 2003